Disposable Asepsis Safe Injection Needle Market – Regional Analysis
On the basis of region, the global disposable asepsis safe injection needle market is segmented into North America, Latin America, Europe, Middle East, Asia Pacific, and Africa. North America disposable asepsis safe injection needle market accounted to exhibit higher market share, owing to the growing geriatric population which in turn is rising the requirement of frequent hospitalizations due to aging-associated diseases such as heart disease, stroke, diabetes and falling injuries.
Ask For Sample Copy of This Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/1852
According to Population Reference Bureau, 2018 data findings, number of Americans ages 65 and older is projected to more than double from 46 million (2018) to over 98 million by 2060. This increasing patient population expected to increase to increase the demand of this needles this region.
The number of diagnostic tests carried out for any disease require the blood sample results, which is increasing the demand for disposable asepsis safe injection needles. In Africa, according to the World Health Organization, almost 85% of all the chronic disease needs blood test, which leads to increasing demand for safe and disposable syringes and needles from these countries.
Injection needles are most frequently used in medical procedures. According to the World Health Organization (WHO) 2012 data findings, every year at least 16 billion injections are being administered in emerging economies out of which, around 95% are given in curative care. Also, immunization accounts for around 3% of all the injections. Furthermore, according to the World Health Organization (WHO), nine out of 10 patients who visit a primary healthcare provider receive an injection.
Moreover, unsafe injection practices cause severe infections, thereby causing severe risk of blood borne disease to the patients. Unsafe injection practices such as reuse of syringes and needles, improper or no sterilization of needles, and poor collection and disposal of dirty injection equipment leads to increasing adoption of disposable injection needles, thereby boosting growth of the Disposable Asepsis Safe Injection Needle Market.
Disposable Asepsis Safe Injection Needle Market Drivers
Increasing awareness regarding safe injection practices by healthcare regulatory organizations, in order to minimize the possible risk of infection related to blood-borne viruses (BBVs), will help in boosting the disposable asepsis safe injection needle market growth over the forecast period. For instance, according to the World Health Organization (WHO), in February 2012, unsafe injection led to an estimated 1.3 million early deaths, and an annual burden of US$ 535 million in direct medical costs every year. Moreover, unsafe injection practices are the most common cause of hepatitis C in emerging economies. Unsafe injection practices also leads to the transmission of blood borne pathogens, including hepatitis B virus, hepatitis C virus, and human immunodeficiency virus (HIV).
Increasing prevalence of certain disease conditions such as cancer, HIV/AIDS, diabetes, coronary heart disease, and anemia are driving growth of the disposable asepsis safe injection needle market. Furthermore, increasing number of surgeries and casualty cases, and high demand for blood transfusion are further offering lucrative growth opportunities in the market. According to the Centers for Disease Control and Prevention (CDC), the U.S. reported around 26,203 cases of Lyme disease between 2006 and 2016.
Disposable Asepsis Safe Injection Needle Market – Competitive Landscape
Some of the key players operating in the global disposable asepsis safe injection needle market include Pall Corporation, C. R. Bard, Inc., Becton, Dickinson and Company, Vita Needle Company, Thomas Scientific, Inc., Retractable Technologies, Inc., and Terumo Corporation.